News

Assess CVD risk in schizophrenia

26-Oct-07

GPs have been urged to take more responsibility for the physical health of patients diagnosed with schizophrenia.

Metabolic and cardiovascular risk factors must be monitored in these patients, say a collection of advocacy groups including the National Obesity Forum.

Weight gain is a multi-pronged problem in schizophrenia. As well as issues over cardiovascular health, there are concerns that some patients discontinue antipsychotic drugs when they put on weight.

Although the management of severe psychiatric care should continue to be the preserve of specialist services, GPs should be getting more involved with day-to-day management of these patients, say the charities.

The GMS quality framework mental health domain has 23 points for giving patients with schizophrenia health promotion advice depending on their health status. But in the manifesto developed by the advocacy groups, GPs are urged to embrace this role 'enthusiastically'. It called on GPs to set up screening systems to help manage metabolic and cardiovascular risks.

This could lead to referring a patient back to secondary care for a review of their antipsychotic medication.

Dr Dave Tomson, a Tyneside GP with an interest in mental health, called for more flexible support from mental health services.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

nMRCGP exam update - Evidence for aspirin use

Contributed by Dr Louise Newson, a GP in the West Midlands. Read more

RCGP curriculum - Introducing the GP curriculum

Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more

Alcohol problems in young people

Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more

Show all articles

 

Latest Clinical Articles

Altitude-related illness

Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more

Clinical Review - Subfertility in women

Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more

Stable angina pectoris

Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more

Show all clinical articles

MIMS Product News

Relistor

New drug - Relistor

Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more

Thalidomide available in the UK

Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more

MMR catch-up programme

The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more

Jobs

 

Job of the Week